img

Global SGLT2 Inhibitors Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global SGLT2 Inhibitors Market Insights, Forecast to 2034

The global SGLT2 Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for SGLT2 Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for SGLT2 Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for SGLT2 Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of SGLT2 Inhibitors include AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Hansoh Pharmaceutical Group, Orifarm, Starpharma and Sandoz, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for SGLT2 Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of SGLT2 Inhibitors, also provides the sales of main regions and countries. Highlights of the upcoming market potential for SGLT2 Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the SGLT2 Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global SGLT2 Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for SGLT2 Inhibitors sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Hansoh Pharmaceutical Group, Orifarm, Starpharma and Sandoz, etc.



By Company


AstraZeneca
Hengrui Medicine
Johnson and Johnson
Kelun Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Hansoh Pharmaceutical Group
Orifarm
Starpharma
Sandoz
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Segment by Type
Canagliflozin
Dapagliflozin
Canagliflozin
Other

Segment by Application


Single Drug
Combination Medication

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of SGLT2 Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of SGLT2 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SGLT2 Inhibitors sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 SGLT2 Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global SGLT2 Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Canagliflozin
1.2.3 Dapagliflozin
1.2.4 Canagliflozin
1.2.5 Other
1.3 Market by Application
1.3.1 Global SGLT2 Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Single Drug
1.3.3 Combination Medication
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global SGLT2 Inhibitors Sales Estimates and Forecasts 2018-2034
2.2 Global SGLT2 Inhibitors Revenue by Region
2.2.1 Global SGLT2 Inhibitors Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global SGLT2 Inhibitors Revenue by Region (2018-2024)
2.2.3 Global SGLT2 Inhibitors Revenue by Region (2024-2034)
2.2.4 Global SGLT2 Inhibitors Revenue Market Share by Region (2018-2034)
2.3 Global SGLT2 Inhibitors Sales Estimates and Forecasts 2018-2034
2.4 Global SGLT2 Inhibitors Sales by Region
2.4.1 Global SGLT2 Inhibitors Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global SGLT2 Inhibitors Sales by Region (2018-2024)
2.4.3 Global SGLT2 Inhibitors Sales by Region (2024-2034)
2.4.4 Global SGLT2 Inhibitors Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global SGLT2 Inhibitors Sales by Manufacturers
3.1.1 Global SGLT2 Inhibitors Sales by Manufacturers (2018-2024)
3.1.2 Global SGLT2 Inhibitors Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SGLT2 Inhibitors in 2022
3.2 Global SGLT2 Inhibitors Revenue by Manufacturers
3.2.1 Global SGLT2 Inhibitors Revenue by Manufacturers (2018-2024)
3.2.2 Global SGLT2 Inhibitors Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by SGLT2 Inhibitors Revenue in 2022
3.3 Global Key Players of SGLT2 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global SGLT2 Inhibitors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global SGLT2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of SGLT2 Inhibitors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of SGLT2 Inhibitors, Product Offered and Application
3.8 Global Key Manufacturers of SGLT2 Inhibitors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global SGLT2 Inhibitors Sales by Type
4.1.1 Global SGLT2 Inhibitors Historical Sales by Type (2018-2024)
4.1.2 Global SGLT2 Inhibitors Forecasted Sales by Type (2024-2034)
4.1.3 Global SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
4.2 Global SGLT2 Inhibitors Revenue by Type
4.2.1 Global SGLT2 Inhibitors Historical Revenue by Type (2018-2024)
4.2.2 Global SGLT2 Inhibitors Forecasted Revenue by Type (2024-2034)
4.2.3 Global SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
4.3 Global SGLT2 Inhibitors Price by Type
4.3.1 Global SGLT2 Inhibitors Price by Type (2018-2024)
4.3.2 Global SGLT2 Inhibitors Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global SGLT2 Inhibitors Sales by Application
5.1.1 Global SGLT2 Inhibitors Historical Sales by Application (2018-2024)
5.1.2 Global SGLT2 Inhibitors Forecasted Sales by Application (2024-2034)
5.1.3 Global SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
5.2 Global SGLT2 Inhibitors Revenue by Application
5.2.1 Global SGLT2 Inhibitors Historical Revenue by Application (2018-2024)
5.2.2 Global SGLT2 Inhibitors Forecasted Revenue by Application (2024-2034)
5.2.3 Global SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
5.3 Global SGLT2 Inhibitors Price by Application
5.3.1 Global SGLT2 Inhibitors Price by Application (2018-2024)
5.3.2 Global SGLT2 Inhibitors Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada SGLT2 Inhibitors Market Size by Type
6.1.1 US & Canada SGLT2 Inhibitors Sales by Type (2018-2034)
6.1.2 US & Canada SGLT2 Inhibitors Revenue by Type (2018-2034)
6.2 US & Canada SGLT2 Inhibitors Market Size by Application
6.2.1 US & Canada SGLT2 Inhibitors Sales by Application (2018-2034)
6.2.2 US & Canada SGLT2 Inhibitors Revenue by Application (2018-2034)
6.3 US & Canada SGLT2 Inhibitors Market Size by Country
6.3.1 US & Canada SGLT2 Inhibitors Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada SGLT2 Inhibitors Sales by Country (2018-2034)
6.3.3 US & Canada SGLT2 Inhibitors Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe SGLT2 Inhibitors Market Size by Type
7.1.1 Europe SGLT2 Inhibitors Sales by Type (2018-2034)
7.1.2 Europe SGLT2 Inhibitors Revenue by Type (2018-2034)
7.2 Europe SGLT2 Inhibitors Market Size by Application
7.2.1 Europe SGLT2 Inhibitors Sales by Application (2018-2034)
7.2.2 Europe SGLT2 Inhibitors Revenue by Application (2018-2034)
7.3 Europe SGLT2 Inhibitors Market Size by Country
7.3.1 Europe SGLT2 Inhibitors Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe SGLT2 Inhibitors Sales by Country (2018-2034)
7.3.3 Europe SGLT2 Inhibitors Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China SGLT2 Inhibitors Market Size
8.1.1 China SGLT2 Inhibitors Sales (2018-2034)
8.1.2 China SGLT2 Inhibitors Revenue (2018-2034)
8.2 China SGLT2 Inhibitors Market Size by Application
8.2.1 China SGLT2 Inhibitors Sales by Application (2018-2034)
8.2.2 China SGLT2 Inhibitors Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia SGLT2 Inhibitors Market Size by Type
9.1.1 Asia SGLT2 Inhibitors Sales by Type (2018-2034)
9.1.2 Asia SGLT2 Inhibitors Revenue by Type (2018-2034)
9.2 Asia SGLT2 Inhibitors Market Size by Application
9.2.1 Asia SGLT2 Inhibitors Sales by Application (2018-2034)
9.2.2 Asia SGLT2 Inhibitors Revenue by Application (2018-2034)
9.3 Asia SGLT2 Inhibitors Sales by Region
9.3.1 Asia SGLT2 Inhibitors Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia SGLT2 Inhibitors Revenue by Region (2018-2034)
9.3.3 Asia SGLT2 Inhibitors Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America SGLT2 Inhibitors Market Size by Type
10.1.1 Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America SGLT2 Inhibitors Market Size by Application
10.2.1 Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Country
10.3.1 Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AstraZeneca SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Hengrui Medicine
11.2.1 Hengrui Medicine Company Information
11.2.2 Hengrui Medicine Overview
11.2.3 Hengrui Medicine SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Hengrui Medicine SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hengrui Medicine Recent Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Information
11.3.2 Johnson and Johnson Overview
11.3.3 Johnson and Johnson SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Johnson and Johnson SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson and Johnson Recent Developments
11.4 Kelun Pharmaceutical
11.4.1 Kelun Pharmaceutical Company Information
11.4.2 Kelun Pharmaceutical Overview
11.4.3 Kelun Pharmaceutical SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Kelun Pharmaceutical SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kelun Pharmaceutical Recent Developments
11.5 Chia Tai-Tianqing Pharmaceutical
11.5.1 Chia Tai-Tianqing Pharmaceutical Company Information
11.5.2 Chia Tai-Tianqing Pharmaceutical Overview
11.5.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
11.6 Hansoh Pharmaceutical Group
11.6.1 Hansoh Pharmaceutical Group Company Information
11.6.2 Hansoh Pharmaceutical Group Overview
11.6.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hansoh Pharmaceutical Group Recent Developments
11.7 Orifarm
11.7.1 Orifarm Company Information
11.7.2 Orifarm Overview
11.7.3 Orifarm SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Orifarm SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Orifarm Recent Developments
11.8 Starpharma
11.8.1 Starpharma Company Information
11.8.2 Starpharma Overview
11.8.3 Starpharma SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Starpharma SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Starpharma Recent Developments
11.9 Sandoz
11.9.1 Sandoz Company Information
11.9.2 Sandoz Overview
11.9.3 Sandoz SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sandoz SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sandoz Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Bristol-Myers Squibb SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol-Myers Squibb Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Information
11.11.2 Boehringer Ingelheim Overview
11.11.3 Boehringer Ingelheim SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Boehringer Ingelheim SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Overview
11.12.3 Merck SGLT2 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Merck SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 SGLT2 Inhibitors Industry Chain Analysis
12.2 SGLT2 Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 SGLT2 Inhibitors Production Mode & Process
12.4 SGLT2 Inhibitors Sales and Marketing
12.4.1 SGLT2 Inhibitors Sales Channels
12.4.2 SGLT2 Inhibitors Distributors
12.5 SGLT2 Inhibitors Customers
13 Market Dynamics
13.1 SGLT2 Inhibitors Industry Trends
13.2 SGLT2 Inhibitors Market Drivers
13.3 SGLT2 Inhibitors Market Challenges
13.4 SGLT2 Inhibitors Market Restraints
14 Key Findings in The Global SGLT2 Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global SGLT2 Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Canagliflozin
Table 3. Major Manufacturers of Dapagliflozin
Table 4. Major Manufacturers of Canagliflozin
Table 5. Major Manufacturers of Other
Table 6. Global SGLT2 Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global SGLT2 Inhibitors Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global SGLT2 Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global SGLT2 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global SGLT2 Inhibitors Revenue Market Share by Region (2018-2024)
Table 11. Global SGLT2 Inhibitors Revenue Market Share by Region (2024-2034)
Table 12. Global SGLT2 Inhibitors Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 13. Global SGLT2 Inhibitors Sales by Region (2018-2024) & (Tablets)
Table 14. Global SGLT2 Inhibitors Sales by Region (2024-2034) & (Tablets)
Table 15. Global SGLT2 Inhibitors Sales Market Share by Region (2018-2024)
Table 16. Global SGLT2 Inhibitors Sales Market Share by Region (2024-2034)
Table 17. Global SGLT2 Inhibitors Sales by Manufacturers (2018-2024) & (Tablets)
Table 18. Global SGLT2 Inhibitors Sales Share by Manufacturers (2018-2024)
Table 19. Global SGLT2 Inhibitors Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global SGLT2 Inhibitors Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of SGLT2 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. SGLT2 Inhibitors Price by Manufacturers 2018-2024 (US$/Tablets)
Table 23. Global SGLT2 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global SGLT2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SGLT2 Inhibitors as of 2022)
Table 25. Global Key Manufacturers of SGLT2 Inhibitors, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of SGLT2 Inhibitors, Product Offered and Application
Table 27. Global Key Manufacturers of SGLT2 Inhibitors, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global SGLT2 Inhibitors Sales by Type (2018-2024) & (Tablets)
Table 30. Global SGLT2 Inhibitors Sales by Type (2024-2034) & (Tablets)
Table 31. Global SGLT2 Inhibitors Sales Share by Type (2018-2024)
Table 32. Global SGLT2 Inhibitors Sales Share by Type (2024-2034)
Table 33. Global SGLT2 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global SGLT2 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global SGLT2 Inhibitors Revenue Share by Type (2018-2024)
Table 36. Global SGLT2 Inhibitors Revenue Share by Type (2024-2034)
Table 37. SGLT2 Inhibitors Price by Type (2018-2024) & (US$/Tablets)
Table 38. Global SGLT2 Inhibitors Price Forecast by Type (2024-2034) & (US$/Tablets)
Table 39. Global SGLT2 Inhibitors Sales by Application (2018-2024) & (Tablets)
Table 40. Global SGLT2 Inhibitors Sales by Application (2024-2034) & (Tablets)
Table 41. Global SGLT2 Inhibitors Sales Share by Application (2018-2024)
Table 42. Global SGLT2 Inhibitors Sales Share by Application (2024-2034)
Table 43. Global SGLT2 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global SGLT2 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global SGLT2 Inhibitors Revenue Share by Application (2018-2024)
Table 46. Global SGLT2 Inhibitors Revenue Share by Application (2024-2034)
Table 47. SGLT2 Inhibitors Price by Application (2018-2024) & (US$/Tablets)
Table 48. Global SGLT2 Inhibitors Price Forecast by Application (2024-2034) & (US$/Tablets)
Table 49. US & Canada SGLT2 Inhibitors Sales by Type (2018-2024) & (Tablets)
Table 50. US & Canada SGLT2 Inhibitors Sales by Type (2024-2034) & (Tablets)
Table 51. US & Canada SGLT2 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada SGLT2 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 53. US & Canada SGLT2 Inhibitors Sales by Application (2018-2024) & (Tablets)
Table 54. US & Canada SGLT2 Inhibitors Sales by Application (2024-2034) & (Tablets)
Table 55. US & Canada SGLT2 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada SGLT2 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 57. US & Canada SGLT2 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. US & Canada SGLT2 Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada SGLT2 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 60. US & Canada SGLT2 Inhibitors Sales by Country (2018-2024) & (Tablets)
Table 61. US & Canada SGLT2 Inhibitors Sales by Country (2024-2034) & (Tablets)
Table 62. Europe SGLT2 Inhibitors Sales by Type (2018-2024) & (Tablets)
Table 63. Europe SGLT2 Inhibitors Sales by Type (2024-2034) & (Tablets)
Table 64. Europe SGLT2 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe SGLT2 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 66. Europe SGLT2 Inhibitors Sales by Application (2018-2024) & (Tablets)
Table 67. Europe SGLT2 Inhibitors Sales by Application (2024-2034) & (Tablets)
Table 68. Europe SGLT2 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe SGLT2 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 70. Europe SGLT2 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 71. Europe SGLT2 Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe SGLT2 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 73. Europe SGLT2 Inhibitors Sales by Country (2018-2024) & (Tablets)
Table 74. Europe SGLT2 Inhibitors Sales by Country (2024-2034) & (Tablets)
Table 75. China SGLT2 Inhibitors Sales by Type (2018-2024) & (Tablets)
Table 76. China SGLT2 Inhibitors Sales by Type (2024-2034) & (Tablets)
Table 77. China SGLT2 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 78. China SGLT2 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 79. China SGLT2 Inhibitors Sales by Application (2018-2024) & (Tablets)
Table 80. China SGLT2 Inhibitors Sales by Application (2024-2034) & (Tablets)
Table 81. China SGLT2 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 82. China SGLT2 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 83. Asia SGLT2 Inhibitors Sales by Type (2018-2024) & (Tablets)
Table 84. Asia SGLT2 Inhibitors Sales by Type (2024-2034) & (Tablets)
Table 85. Asia SGLT2 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia SGLT2 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 87. Asia SGLT2 Inhibitors Sales by Application (2018-2024) & (Tablets)
Table 88. Asia SGLT2 Inhibitors Sales by Application (2024-2034) & (Tablets)
Table 89. Asia SGLT2 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia SGLT2 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 91. Asia SGLT2 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 92. Asia SGLT2 Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia SGLT2 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 94. Asia SGLT2 Inhibitors Sales by Region (2018-2024) & (Tablets)
Table 95. Asia SGLT2 Inhibitors Sales by Region (2024-2034) & (Tablets)
Table 96. Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Type (2018-2024) & (Tablets)
Table 97. Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Type (2024-2034) & (Tablets)
Table 98. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 100. Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Application (2018-2024) & (Tablets)
Table 101. Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Application (2024-2034) & (Tablets)
Table 102. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 104. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 105. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Country (2018-2024) & (Tablets)
Table 108. Middle East, Africa and Latin America SGLT2 Inhibitors Sales by Country (2024-2034) & (Tablets)
Table 109. AstraZeneca Company Information
Table 110. AstraZeneca Description and Major Businesses
Table 111. AstraZeneca SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 112. AstraZeneca SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. AstraZeneca Recent Developments
Table 114. Hengrui Medicine Company Information
Table 115. Hengrui Medicine Description and Major Businesses
Table 116. Hengrui Medicine SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 117. Hengrui Medicine SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Hengrui Medicine Recent Developments
Table 119. Johnson and Johnson Company Information
Table 120. Johnson and Johnson Description and Major Businesses
Table 121. Johnson and Johnson SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 122. Johnson and Johnson SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Johnson and Johnson Recent Developments
Table 124. Kelun Pharmaceutical Company Information
Table 125. Kelun Pharmaceutical Description and Major Businesses
Table 126. Kelun Pharmaceutical SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 127. Kelun Pharmaceutical SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Kelun Pharmaceutical Recent Developments
Table 129. Chia Tai-Tianqing Pharmaceutical Company Information
Table 130. Chia Tai-Tianqing Pharmaceutical Description and Major Businesses
Table 131. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 132. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Chia Tai-Tianqing Pharmaceutical Recent Developments
Table 134. Hansoh Pharmaceutical Group Company Information
Table 135. Hansoh Pharmaceutical Group Description and Major Businesses
Table 136. Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 137. Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Hansoh Pharmaceutical Group Recent Developments
Table 139. Orifarm Company Information
Table 140. Orifarm Description and Major Businesses
Table 141. Orifarm SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 142. Orifarm SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Orifarm Recent Developments
Table 144. Starpharma Company Information
Table 145. Starpharma Description and Major Businesses
Table 146. Starpharma SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 147. Starpharma SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Starpharma Recent Developments
Table 149. Sandoz Company Information
Table 150. Sandoz Description and Major Businesses
Table 151. Sandoz SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 152. Sandoz SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Sandoz Recent Developments
Table 154. Bristol-Myers Squibb Company Information
Table 155. Bristol-Myers Squibb Description and Major Businesses
Table 156. Bristol-Myers Squibb SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 157. Bristol-Myers Squibb SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Bristol-Myers Squibb Recent Developments
Table 159. Boehringer Ingelheim Company Information
Table 160. Boehringer Ingelheim Description and Major Businesses
Table 161. Boehringer Ingelheim SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 162. Boehringer Ingelheim SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Boehringer Ingelheim Recent Developments
Table 164. Merck Company Information
Table 165. Merck Description and Major Businesses
Table 166. Merck SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2018-2024)
Table 167. Merck SGLT2 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Merck Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. SGLT2 Inhibitors Distributors List
Table 172. SGLT2 Inhibitors Customers List
Table 173. SGLT2 Inhibitors Market Trends
Table 174. SGLT2 Inhibitors Market Drivers
Table 175. SGLT2 Inhibitors Market Challenges
Table 176. SGLT2 Inhibitors Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. SGLT2 Inhibitors Product Picture
Figure 2. Global SGLT2 Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global SGLT2 Inhibitors Market Share by Type in 2022 & 2034
Figure 4. Canagliflozin Product Picture
Figure 5. Dapagliflozin Product Picture
Figure 6. Canagliflozin Product Picture
Figure 7. Other Product Picture
Figure 8. Global SGLT2 Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global SGLT2 Inhibitors Market Share by Application in 2022 & 2034
Figure 10. Single Drug
Figure 11. Combination Medication
Figure 12. SGLT2 Inhibitors Report Years Considered
Figure 13. Global SGLT2 Inhibitors Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global SGLT2 Inhibitors Revenue 2018-2034 (US$ Million)
Figure 15. Global SGLT2 Inhibitors Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global SGLT2 Inhibitors Revenue Market Share by Region (2018-2034)
Figure 17. Global SGLT2 Inhibitors Sales 2018-2034 ((Tablets)
Figure 18. Global SGLT2 Inhibitors Sales Market Share by Region (2018-2034)
Figure 19. US & Canada SGLT2 Inhibitors Sales YoY (2018-2034) & (Tablets)
Figure 20. US & Canada SGLT2 Inhibitors Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe SGLT2 Inhibitors Sales YoY (2018-2034) & (Tablets)
Figure 22. Europe SGLT2 Inhibitors Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China SGLT2 Inhibitors Sales YoY (2018-2034) & (Tablets)
Figure 24. China SGLT2 Inhibitors Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Asia (excluding China) SGLT2 Inhibitors Sales YoY (2018-2034) & (Tablets)
Figure 26. Asia (excluding China) SGLT2 Inhibitors Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America SGLT2 Inhibitors Sales YoY (2018-2034) & (Tablets)
Figure 28. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The SGLT2 Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of SGLT2 Inhibitors in the World: Market Share by SGLT2 Inhibitors Revenue in 2022
Figure 31. Global SGLT2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
Figure 33. Global SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
Figure 34. Global SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
Figure 35. Global SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
Figure 36. US & Canada SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
Figure 37. US & Canada SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
Figure 38. US & Canada SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
Figure 39. US & Canada SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada SGLT2 Inhibitors Revenue Share by Country (2018-2034)
Figure 41. US & Canada SGLT2 Inhibitors Sales Share by Country (2018-2034)
Figure 42. U.S. SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 43. Canada SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 44. Europe SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
Figure 45. Europe SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
Figure 46. Europe SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
Figure 47. Europe SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
Figure 48. Europe SGLT2 Inhibitors Revenue Share by Country (2018-2034)
Figure 49. Europe SGLT2 Inhibitors Sales Share by Country (2018-2034)
Figure 50. Germany SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 51. France SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 52. U.K. SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 53. Italy SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 54. Russia SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 55. China SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
Figure 56. China SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
Figure 57. China SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
Figure 58. China SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
Figure 59. Asia SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
Figure 60. Asia SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
Figure 61. Asia SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
Figure 62. Asia SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
Figure 63. Asia SGLT2 Inhibitors Revenue Share by Region (2018-2034)
Figure 64. Asia SGLT2 Inhibitors Sales Share by Region (2018-2034)
Figure 65. Japan SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 66. South Korea SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 67. China Taiwan SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 68. Southeast Asia SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 69. India SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 70. Middle East, Africa and Latin America SGLT2 Inhibitors Sales Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America SGLT2 Inhibitors Sales Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America SGLT2 Inhibitors Revenue Share by Country (2018-2034)
Figure 75. Middle East, Africa and Latin America SGLT2 Inhibitors Sales Share by Country (2018-2034)
Figure 76. Brazil SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 77. Mexico SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 78. Turkey SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 79. Israel SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 80. GCC Countries SGLT2 Inhibitors Revenue (2018-2034) & (US$ Million)
Figure 81. SGLT2 Inhibitors Value Chain
Figure 82. SGLT2 Inhibitors Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries